KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Ginkgo Bioworks Holdings (DNA) Accumulated Depreciation & Amortization (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Accumulated Depreciation & Amortization for 4 consecutive years, with $120.7 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Accumulated Depreciation & Amortization changed N/A year-over-year to $120.7 million, compared with a TTM value of $120.7 million through Sep 2023, changed N/A, and an annual FY2022 reading of $92.8 million, up 51.93% over the prior year.
  • Accumulated Depreciation & Amortization was $120.7 million for Q3 2023 at Ginkgo Bioworks Holdings, up from $118.5 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $120.7 million in Q3 2023 and bottomed at $33.8 million in Q4 2020.
  • Average Accumulated Depreciation & Amortization over 4 years is $85.4 million, with a median of $92.8 million recorded in 2022.
  • The sharpest move saw Accumulated Depreciation & Amortization surged 80.74% in 2021, then skyrocketed 51.93% in 2022.
  • Year by year, Accumulated Depreciation & Amortization stood at $33.8 million in 2020, then surged by 80.74% to $61.1 million in 2021, then surged by 51.93% to $92.8 million in 2022, then soared by 30.14% to $120.7 million in 2023.
  • Business Quant data shows Accumulated Depreciation & Amortization for DNA at $120.7 million in Q3 2023, $118.5 million in Q2 2023, and $92.8 million in Q4 2022.